CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −350 | $323.01 | $113K | 22,344 |
| 2026-03-04 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −767 | $323.84 | $248K | 21,577 |
| 2026-03-04 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −272 | $324.88 | $88K | 21,305 |
| 2026-03-04 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −208 | $325.67 | $68K | 21,097 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −135 | $319.03 | $43K | 98,493 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −129 | $320.01 | $41K | 98,364 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −274 | $320.81 | $88K | 98,090 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −368 | $321.82 | $118K | 97,722 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −444 | $323.01 | $143K | 97,278 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −973 | $323.84 | $315K | 96,305 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −345 | $324.88 | $112K | 95,960 |
| 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | Sale | −265 | $325.67 | $86K | 95,695 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −114 | $319.03 | $36K | 64,159 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −109 | $320.01 | $35K | 64,050 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −230 | $320.81 | $74K | 63,820 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −309 | $321.82 | $99K | 63,511 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −374 | $323.01 | $121K | 63,137 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −818 | $323.84 | $265K | 62,319 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −291 | $324.88 | $95K | 62,028 |
| 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −223 | $325.67 | $73K | 61,805 |
Page 4 of 41 · 816 trades